Table 5. Complications and outcome.
| Global | AKI | No AKI | p | |
|---|---|---|---|---|
| (n = 1642) | (n = 618, 40.1%) | (n = 923, 59.9%) | ||
| Complications | ||||
| Ventilator-associated pneumonia n (%) | 477 (30.5) | 229 (37.7) | 231 (25.6) | <0.001 |
| Catheter-related bloodstream infections n (%) | 280 (18.0) | 126 (20.9) | 145 (16.0) | 0.015 |
| Urinary tract infections n (%) | 229 (14.8) | 112 (18.6) | 111 (12.4) | 0.001 |
| Thrombotic events n (%) | 236 (15.3) | 109 (18.1) | 118 (13.2) | 0.010 |
| Outcome | ||||
| Length stay in ICU median (IQR) | 14.0 (6.0,27.0) | 18.0 (8.0,33.0) | 12.0 (5.0,24.0) | <0.001 |
| Length stay in Hospital median (IQR) | 26.5 (15.0,44.0) | 29.0 (16.0,52.0) | 25.0(15.0,39.0) | 0.002 |
| ICU mortality n (%) | 469 (29.7) | 296 (48.2) | 162 (17.7) | <0.001 |
| Global mortality n (%) | 493 (31.2) | 311 (51.1) | 172 (19) | <0.001 |
ICU–Intensive Care Unit
IQR- Inter Quartile Range.